ThesisAngiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma
ThesisAngiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma
ThesisAngiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma
ThesisAngiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma
ThesisSerum laminin and syndecan -1 : Novel biomarkers in predicting liver fibrosis stage in patients with hepatocllular carcinoma
ThesisSerum laminin and syndecan -1 : Novel biomarkers in predicting liver fibrosis stage in patients with hepatocllular carcinoma
ThesisEvaluation of annexin II and follistatin as potential serum markers for hepatocellular carcinoma
ThesisEvaluation of annexin II and follistatin as potential serum markers for hepatocellular carcinoma
ThesisCorrelation between CA 19-9 and alpha fetoprotein (AFP) in diagnosed cases of hepatocellular carcinoma
ThesisCorrelation between CA 19-9 and alpha fetoprotein (AFP) in diagnosed cases of hepatocellular carcinoma